Bifogade filer
PDF
Kurs
-11,81%
Likviditet
64,5 MSEK
Kalender
| Tid* | ||
| 2023-02-22 | - | Bokslutskommuniké 2022 |
| 2022-12-05 | - | Extra Bolagsstämma 2022 |
| 2022-07-21 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-31 | - | Årsstämma |
| 2022-05-06 | - | X-dag ordinarie utdelning KARO 0.00 SEK |
| 2022-02-25 | - | Bokslutskommuniké 2021 |
| 2021-10-28 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-22 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-23 | - | X-dag ordinarie utdelning KARO 0.00 SEK |
| 2021-04-21 | - | Årsstämma |
| 2021-04-21 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-10-30 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-21 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-25 | - | Årsstämma |
| 2020-04-30 | - | X-dag ordinarie utdelning KARO 0.00 SEK |
| 2020-04-29 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | - | Bokslutskommuniké 2019 |
| 2019-11-15 | - | Kvartalsrapport 2019-Q3 |
| 2019-09-20 | - | Extra Bolagsstämma 2019 |
| 2019-07-19 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-17 | - | X-dag ordinarie utdelning KARO 0.00 SEK |
| 2019-05-16 | - | Årsstämma |
| 2019-04-26 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-14 | - | Bokslutskommuniké 2018 |
| 2018-11-01 | - | Kvartalsrapport 2018-Q3 |
| 2018-07-19 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-04 | - | X-dag ordinarie utdelning KARO 0.30 SEK |
| 2018-05-03 | - | Årsstämma |
| 2018-04-26 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-22 | - | Bokslutskommuniké 2017 |
| 2017-12-08 | - | Extra Bolagsstämma 2017 |
| 2017-11-02 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-24 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-12 | - | X-dag ordinarie utdelning KARO 0.28 SEK |
| 2017-05-12 | - | X-dag bonusutdelning KARO 0.22 |
| 2017-05-11 | - | Årsstämma |
| 2017-05-10 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-28 | - | Bokslutskommuniké 2016 |
| 2016-10-27 | - | Kvartalsrapport 2016-Q3 |
| 2016-07-15 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-13 | - | X-dag ordinarie utdelning KARO 0.00 SEK |
| 2016-05-12 | - | Årsstämma |
| 2016-05-12 | - | Kvartalsrapport 2016-Q1 |
| 2016-03-16 | - | Extra Bolagsstämma 2016 |
| 2016-02-12 | - | Bokslutskommuniké 2015 |
| 2015-10-29 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-26 | - | Split KARO 20:1 |
| 2015-07-10 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-30 | - | X-dag ordinarie utdelning KARO 0.00 SEK |
| 2015-04-29 | - | Årsstämma |
| 2015-04-29 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-13 | - | Bokslutskommuniké 2014 |
| 2014-10-29 | - | Kvartalsrapport 2014-Q3 |
| 2014-07-11 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-09 | - | X-dag ordinarie utdelning KARO 0.00 SEK |
| 2014-05-08 | - | Årsstämma |
| 2014-05-08 | - | Kvartalsrapport 2014-Q1 |
| 2014-03-17 | - | Extra Bolagsstämma 2014 |
| 2014-02-13 | - | Bokslutskommuniké 2013 |
| 2013-10-25 | - | Kvartalsrapport 2013-Q3 |
| 2013-07-12 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-08 | - | X-dag ordinarie utdelning KARO 0.00 SEK |
| 2013-05-07 | - | Årsstämma |
| 2013-05-07 | - | Kvartalsrapport 2013-Q1 |
| 2013-03-13 | - | 15-7 2013 |
| 2013-02-12 | - | Bokslutskommuniké 2012 |
| 2013-02-12 | - | Analytiker möte 2013 |
| 2012-11-19 | - | Extra Bolagsstämma 2012 |
| 2012-10-24 | - | Kvartalsrapport 2012-Q3 |
| 2012-07-13 | - | Kvartalsrapport 2012-Q2 |
| 2012-06-12 | - | Årsstämma |
| 2012-04-30 | - | X-dag ordinarie utdelning KARO 0.00 SEK |
| 2012-04-27 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-08 | - | Bokslutskommuniké 2011 |
| 2011-11-29 | - | 15-7 2011 |
| 2011-10-25 | - | Kvartalsrapport 2011-Q3 |
| 2011-07-13 | - | Kvartalsrapport 2011-Q2 |
| 2011-04-28 | - | X-dag ordinarie utdelning KARO 0.00 SEK |
| 2011-04-27 | - | Årsstämma |
| 2011-04-27 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-09 | - | Bokslutskommuniké 2010 |
| 2010-10-26 | - | Kvartalsrapport 2010-Q3 |
| 2010-07-13 | - | Kvartalsrapport 2010-Q2 |
| 2010-04-26 | - | X-dag ordinarie utdelning KARO 0.00 SEK |
| 2010-04-23 | - | Årsstämma |
| 2010-04-22 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-09 | - | Bokslutskommuniké 2009 |
| 2009-10-22 | - | Kvartalsrapport 2009-Q3 |
| 2009-07-14 | - | Kvartalsrapport 2009-Q2 |
| 2009-04-27 | - | X-dag ordinarie utdelning KARO 0.00 SEK |
| 2009-04-24 | - | Årsstämma |
| 2009-04-22 | - | Kvartalsrapport 2009-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
The board of directors of Karo Pharma Aktiebolag (publ) (the "Company" or "Karo") has resolved to initiate a process to have the Company's shares listed on Nasdaq First North Growth Market and delisted from Nasdaq Stockholm (the "First North Listing"). The First North Listing is expected to be completed during the first half of 2022, in connection with the rights issue intended to repay the bridge loan facility provided to finance the acquisition of Sylphar International NV announced on 22 November 2021.
Karo is on a journey to build a pan-European consumer healthcare company. The ongoing administration, governance and reporting requirements would be simplified (including semi-annual financial reporting), with a consequential reduction in the costs and use of managerial resources associated with having the Company's shares listed on Nasdaq Stockholm. Furthermore, the liquidity in the Company's share has been low since the completion of the tender offer from its largest shareholder, Karo Intressenter AB, in January 2019, which currently holds approximatively 80 percent of the shares and votes in the Company.
The board of directors therefore believes that Nasdaq First North Growth Market, with its more suitable regulatory environment and lower cost of complying with continuing obligations, is a more appropriate listing venue for the Company given its strategy and shareholder base.
Further information on the First North Listing is expected to be provided no later than in connection with a potential resolution by the board of directors of the Company to submit a formal application to have its shares delisted from Nasdaq Stockholm, during the first half of 2022.
For further information, please contact:
Christoffer Lorenzen, CEO, +46 73-501 76 20, christoffer.lorenzen@karopharma.com
Jon Johnsson, CFO, +46 73-507 88 61, jon.johnsson@karopharma.com
The information was submitted for publication by the contact persons set out above, at 8:00 CET on 15 December 2021.
About Karo Pharma
Karo Pharma delivers smart choices for everyday healthcare. We own and commercialize branded, original over-the-counter products and prescription medicines. Our products are available in more than 60 countries, with Europe and the Nordic region as our core markets. Karo Pharma is headquartered in Stockholm, Sweden and listed on Nasdaq Stockholm Mid Cap.